[{"Assets_0_Q2_USD":165709000.0,"CommonStockSharesOutstanding_0_Q2_shares":37356000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-22653000.0,"NetIncomeLoss_1_Q2_USD":-8605000.0,"NetIncomeLoss_2_Q2_USD":-21623000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":37356000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":37355000.0,"StockholdersEquity_0_Q2_USD":-17777000.0,"EarningsPerShareBasic_1_Q2_USD":-0.23,"EarningsPerShareBasic_2_Q2_USD":-0.58,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]